Strategic Partnership Across Multiple Therapeutic Areas

PPD has a strategic partnership with a mid- to large-sized global biopharmaceutical company specializing in immunology, hematology/oncology and endocrine/metabolic. Over the past eight years, PPD’s relationship with this client has evolved from a single, more transactional trial to a near sole provider partnership, with PPD supporting protocol development and planning. The relationship has been positive over time based on results, excellent cultural alignment and a commitment to developing a unique approach to the partnership. While there have been pain points and frustration on both sides over the years, the relationship has been sustained due to a mutual respect and trust that both organizations can succeed with a jointly developed vision.

program team regularly updated based on operational requirements and experiences. The PPD/client program team had excellent communication and trust, leveraging face-to-face meetings as a key component for managing risks and issues. Over four years of program activity, PPD and client team members did not require a single executive intervention to resolve issues.

Ultimately, the immunology program achieved 100% of the critical development milestones with the only operational blemish being the overall activation cycle times during the 2010-2011 period.